Secondary Metabolites with Anti-Inflammatory Activities from an Actinobacteria Herbidospora daliensis

Molecules. 2022 Mar 14;27(6):1887. doi: 10.3390/molecules27061887.

Abstract

Bioassay-guided fractionation of extracts derived from solid cultures of a Herbidospora daliensis originating from Taiwan led to the isolation of five new compounds, for which we propose the name herbidosporadalins A−E (1−5), one isolated for the first time, herbidosporadalin F (6), together with two known compounds (7 & 8). Their structures were elucidated by spectroscopic analyses, including 1D- and 2D-NMR experiments with those of known analogues, and on the basis of HR-EI-MS mass spectrometry, their anti-inflammatory activities were also evaluated. Of these isolates, herbidosporadalin A (1), B (2), F (6) and G (8) showed NO inhibitory activity, with IC50 values of 11.8 ± 0.9, 7.1 ± 2.9, 17.8 ± 1.7, and 13.3 ± 6.5 μM, stronger than the positive control quercetin (IC50 = 36.8 ± 1.3 μM). To the best of our knowledge, this is the first report on 3,4-seco-friedelane metabolites (5, 6 & 8) from the genus Herbidospora.

Keywords: Herbidospora daliensis; anti-inflammatory activities; streptosporangiaceae; triterpenoids.

MeSH terms

  • Actinobacteria*
  • Actinomycetales*
  • Anti-Inflammatory Agents / pharmacology
  • Taiwan

Substances

  • Anti-Inflammatory Agents

Supplementary concepts

  • Herbidospora daliensis